Copyright
©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 324-325
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Table 1 PPI dual therapy
Authors | Ome | Amo | Eradication (%) | Healing (%) | Side effect |
Zhou YH[1] | 20 bid × 14 | 500 qid × 14 | 30/33 (91) | 31/33 (94) | 12% |
Zhou YH[1] | 20 qd × 14 | 500 qid × 14 | 31/35 (89) | 32/35 (91) | |
Nie YQ[2] | 20 bid × 14 | 500 qid × 14 | 10/13 (77) | 12/13 (92) | 15% |
Li YY[3] | 20 bid × 14 | 500 qid × 14 | 8/11 (73) | 9/11 (82) | |
Hu FL[4] | 20 bid × 14 | 750 bid × 14 | 13/22 (59) | 18/22 (82) | |
Zhou Y[5] | 20 bid × 14 | 750 qid × 14 | 30/36 (83) | 36/36 (100) | 2.7% |
Table 2 Furazolidone dual therapy
Authors | Furazolidone | Antibiotics | Eradication (%) | Side effect |
Xiao SD[6] | 100 qid × 14 | CBS 120 qid × 14 | 66/90 (73) | |
Mao PJ[7] | 100 tid × 28 | Ran 150 bid × 28 | 10/17 (59) | 8.9% |
Mao PJ[7] | 100 tid × 28 | Ome 20 qd × 28 | 15/18 (83) | |
Li YN[8] | 200 tid × 7 | CBS 110 qid × 28 | 34/34 (100) | |
100 qid × 7 | ||||
Li YN[8] | 100 tid × 14 | CBS 110 qid × 28 | 21/23 (91) | |
Li YN[8] | 50 tid × 14 | CBS 110 qid × 28 | 13/21 (62) | |
Xi BG[9] | 200 tid × 14 | CBS 110 qid × 28 | 24/24 (100) |
Table 3 Triple therapy with Furazolidone
Authors | Fu | Antibiotics | Antibiotics | Eradication (%) | Side effect |
Liu WZ[10] | 200 bid × 7 | CBS 240 bid × 7 | Cla 500 bid × 7 | 12/12 (100) | 57% |
Liu WZ[10] | 100 bid × 7 | CBS 240 bid × 7 | Cla 250 bid × 7 | 25/27 (93) | 7.4% |
Huang YS[11] | 100 tid × 5 | Met 400 tid × 5 | Genta 40 tid × 5 | 25/26 (96) | |
Xiao SD[6] | 100 qid × 10 | CBS 120 qid × 10 | Met 200 qid × 10 | 74/75 (78) | |
Chen JP[12] | 100 qid × 28 | CBS 120 qid × 28 | Tetra 250 qid × 28 | 35/54 (65) |
Table 4 Hp eradication with CBS triple therapy
Authors | CBS | Amo | Met | Eradication (%) | Side effect |
Jia BQ[13] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 328/440 (87) | 7.8% |
Jia BQ[13] | 240 bid × 14 | 500 bid × 14 | 400 bid × 14 | 139/156 (89) | 7.8% |
Chen SP[14] | 240 bid × 14 | 1000 bid × 14 | 400 bid × 14 | 33/46 (71) | |
Li QN[15] | 240 bid × 14 | 500 bid × 14 | 400 bid × 14 | 13/16 (81) | 37.5% |
Geng Z[16] | 110 qid × 14 | 500 qid × 14 | 200 qid × 14 | 64/76 (84) | |
Zhou LY[17] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 56/73 (77) | |
Li YY[18] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 20/25 (80) | 28% |
Table 5 PPI triple therapy
Authors | PPI | Antibiotics | Cla | Eradication (%) | Side effect |
Chen SP[14] | Ome 20 bid × 7 | Amo 1000 bid × 7 | 500 bid × 7 | 43/48 (90) | 21.1% |
Chen SP[14] | Ome 20 bid × 14 | Amo 1000 bid × 14 | 500 bid × 14 | 45/47 (96) | |
Liu WZ[10] | Lan 30 bid × 7 | Fu 200 bid × 7 | 500 bid × 7 | 11/12 (92) | 10% |
Liu WZ[10] | Lan 30 qd × 7 | Fu 100 bid × 7 | 250 bid × 7 | 27/30 (90) | |
Li QN[15] | Lan 30 bid × 7 | Met 400 bid × 7 | 250 bid × 7 | 14/16 (86) | 18.8% |
Li QN[15] | Lan 30 bid × 7 | Met 400 bid × 7 | 500 bid × 7 | 15/16 (94) | 25% |
- Citation: Li YY, Sha WH. Treatment of Helicobactor pylori infection: analysis of Chinese clinical trials. World J Gastroenterol 2000; 6(3): 324-325
- URL: https://www.wjgnet.com/1007-9327/full/v6/i3/324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i3.324